CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 50 enrolled
Drug / intervention
Assessment of infant body compositionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03575897
NCT03575897N/AActive

Serial Assessment of Body Fat Accrual in Very Preterm Infants: A Pilot Randomized Trial

University of Alabama at Birmingham·interventional·Posted Jul 3, 2018·Updated Jun 15, 2026

In Brief

A clinical study evaluating Assessment of infant body composition for Infant,Premature and 2 related conditions. Active but no longer recruiting, targeting 50 participants across 1 site.

Detailed Summary

Despite evidence that both rapid weight gain and excessive body fat accrual are associated with overweight and obesity, usual neonatal care of preterm infants does not include assessment of body fat accrual. The study hypothesis is that identification of early changes in infant body composition (i.e. amount of fat mass and fat-free mass) reduces % body fat at 3 months of age.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/AActive
201920202021202220232024202520262027
First PostedJul 3, 2018
Enrollment StartSep 10, 2018
Primary CompletionJan 16, 2020
Study CompletionDec 1, 2026
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 8.0 years ago

Interventions

Assessment of infant body compositionother

Serial assessments of infant body composition with air displacement plethysmography in very preterm infants will occur in the first 14 days after birth (baseline measure), at 32 weeks postmenstrual age (PMA), and at 36 weeks PMA or hospital discharge (whichever occurs first)